TABLE 2.
Molecular beacon probes used in this study
| Target gene | Beacon | Sequence (5′-3′)a | Size (bp) | Fluorophore | Quencher | Concnb (μM) multiplex |
|---|---|---|---|---|---|---|
| rtxA | MBrtxA | CGCGATCACCAGAGCGCCAAGAAGTGACTCGTAGATCGCG | 40 | FAMc | Dabcyl | 0.25 |
| epsM | MBepsM | CGCGATGCCACCGACATCGTAACGCTCCGATCGCG | 35 | Texas Red | BHQ2 | 0.25 |
| ompW | MBompW | CCGAAGAAACAACGGCAACCTACAAAGCTTCGG | 33 | Cy5 | BHQ3 | 0.25 |
| tcpA | MBtcpA | CGCGACGCTGAAACCTTACCAAGGCTGACCAAGTCGCG | 38 | Cy3 | BHQ2 | 0.50 |
Molecular beacons were designed using Beacon Designer (version 2.12) software from Premier Biosoft (Palo Alto, CA). Underlined nucleotides indicate the stem sequence of each molecular beacon. MBrtxA, MBepsM, and MBompW were synthesized by TIB MOLBIOL (Berlin, Germany). MBtcpA was synthesized by Proligo (Helios, Singapore).
Remaining PCR constituents were 2 U of FastStart Taq DNA polymerase, 1× PCR buffer, 4 mM MgCl2, 200 μM each deoxynucleoside triphosphate (all from Roche Diagnostics, Laval, Quebec, Canada), and 2 μl of template DNA in a 25-μl final volume.
FAM, 6-carboxyfluorescein.